Oncolys’ Oral COVID-19 Drug Effective in Hamster Model

October 27, 2021
Oncolys BioPharma said on October 26 that it has confirmed the efficacy of its investigational oral COVID-19 treatment OBP-2011 in a pharmacological study conducted in a hamster model. In the study, the drug was given orally to golden Syrian hamsters...read more